Sugar Molecules Called Glycans May Reveal Your True Biological Age
Glycans โ sugar molecules on proteins โ shift with stress, diet, and lifestyle, and may predict disease a decade before symptoms appear.
20 articles
Glycans โ sugar molecules on proteins โ shift with stress, diet, and lifestyle, and may predict disease a decade before symptoms appear.
A 20,000-person study finds IgG glycan patterns track biological aging, predict mortality, and shift toward youth with interventions.
GlycanAge's Dubrovnik conference targets translating 25 years of inflammaging research into real clinical tools for doctors and patients.
A 20,000-person study validates IgG glycans as aging biomarkers, with therapeutic plasma exchange reducing glycan age by 0.4 years per month.
A class of modified amino acids found in dog blood may unlock new ways to measure and track biological aging across species.
BioAge's oral drug BGE-102 dramatically reduced hsCRP and IL-6 in obese participants with elevated inflammation, with a strong safety profile.
A new Nature Communications study shows self-collected fingerprick blood tests reliably flag Alzheimer's biomarkers, enabling earlier risk detection.
Dr. Vineeta Tanwar's GRACE study tests whether reducing glycation stress can improve health outcomes for postmenopausal women.
BioAge's oral drug BGE-102 cut a key cardiovascular risk biomarker by up to 86% in obese patients, rivaling higher doses at just 60mg daily.
New research reveals sugar pushes skin cells into senescence and slows repair, linking diet directly to accelerated skin and systemic aging.
A major UF study finds glucosamine users with mild cognitive impairment are 25% more likely to develop dementia, raising urgent questions for older adults.
BioAge's oral NLRP3 inhibitor BGE-102 cut hsCRP by ~85% in weeks, signaling a potential breakthrough in treating chronic inflammation at scale.
A new wave of biotechs is targeting aging as a root cause, using encapsulated cells and gene therapy to restore lost proteins and reverse decline.
Popular at-home biological age tests promise to reveal your 'true' age, but experts question their accuracy and clinical value.
A landmark study finds Alzheimer's biomarkers in 6% of middle-aged adults, predicting steep cognitive decline within 5 years.
A common immune marker in standard blood tests may predict dementia risk long before cognitive decline begins, a large NYU study finds.
Singapore researchers find calcium alpha-ketoglutarate repairs brain cell communication and restores early memory abilities in Alzheimer's models.
A Japanese study of 495 centenarians finds elevated NfL blood levels strongly linked to worse cognition and 36% higher mortality risk.
Lifespan.io reviews top rejuvenation research advances including voice-based aging biomarkers and a rapamycin-exercise clinical trial.
A new GLP-1 therapy engineered to cross the blood-brain barrier enters Phase II trials, targeting cognitive decline in Parkinson's and Alzheimer's.